OpenURL Connection Search - EBSCO

Connecting you to content on EBSCOhostUNIVERSITÄT DORTMUND

Select item for more details and to access through your institution.

Baricitinib in patients with moderate‐to‐severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phase III trials.
Published in:
British Journal of Dermatology, 2020, v. 183, n. 2, p. 242, doi. 10.1111/bjd.18898
By:
- Simpson, E.L.;
- Lacour, J.‐P.;
- Spelman, L.;
- Galimberti, R.;
- Eichenfield, L.F.;
- Bissonnette, R.;
- King, B.A.;
- Thyssen, J.P.;
- Silverberg, J.I.;
- Bieber, T.;
- Kabashima, K.;
- Tsunemi, Y.;
- Costanzo, A.;
- Guttman‐Yassky, E.;
- Beck, L.A.;
- Janes, J.M.;
- DeLozier, A.M.;
- Gamalo, M.;
- Brinker, D.R.;
- Cardillo, T.
Publication type:
Article
An integrated analysis of herpes virus infections from eight randomized clinical studies of baricitinib in adults with moderate‐to‐severe atopic dermatitis.
Published in:
Journal of the European Academy of Dermatology & Venereology, 2022, v. 36, n. 9, p. 1486, doi. 10.1111/jdv.18193
By:
- Werfel, T.;
- Irvine, A.D.;
- Bangert, C.;
- Seneschal, J.;
- Grond, S.;
- Cardillo, T.;
- Brinker, D.;
- Zhong, J.;
- Riedl, E.;
- Wollenberg, A.
Publication type:
Article